- Home
- DTF vs OM Comparison
DTF vs OM Comparison
Compare DTF & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$5.13
Company Overview
Basic Information| Metric | DTF | OM |
|---|---|---|
| Founded | 1991 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.3M | 96.2M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | DTF | OM |
|---|---|---|
| Price | $11.39 | $5.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $14.00 |
| AVG Volume (30 Days) | 21.1K | ★ 1.8M |
| Earning Date | 01-01-0001 | 02-18-2026 |
| Dividend Yield | ★ 3.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | N/A | ★ $120,069,000.00 |
| Revenue This Year | N/A | $6.23 |
| Revenue Next Year | N/A | $8.87 |
| P/E Ratio | $24.34 | ★ N/A |
| Revenue Growth | N/A | ★ 4.65 |
| 52 Week Low | $10.29 | $3.10 |
| 52 Week High | $11.19 | $21.98 |
Technical Indicators
Market Signals| Indicator | DTF | OM |
|---|---|---|
| Relative Strength Index (RSI) | 55.35 | 54.00 |
| Support Level | $11.39 | $5.00 |
| Resistance Level | $11.50 | $5.63 |
| Average True Range (ATR) | 0.06 | 0.53 |
| MACD | 0.00 | 0.16 |
| Stochastic Oscillator | 53.91 | 50.54 |
Price Performance
Historical Comparison DTF
OM
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing mainly in a diversified portfolio of investment-grade tax-exempt obligations.
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.